<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: QXInteractive; Version: 3.3b -->
    <!-- Field: Doc-Info; Name: Source; Value: IMMY 06302012 S1 80580.xfr; Date: 2012/08/30T21:17:52 -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://imprimispharma.com/role/DocumentAndEntityInformation" xlink:href="immy-20120630.xsd#DocumentAndEntityInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://imprimispharma.com/role/CondensedConsolidatedBalanceSheets" xlink:href="immy-20120630.xsd#CondensedConsolidatedBalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://imprimispharma.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:href="immy-20120630.xsd#CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://imprimispharma.com/role/UnauditedCondensedConsolidatedStatementsOfOperations" xlink:href="immy-20120630.xsd#UnauditedCondensedConsolidatedStatementsOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://imprimispharma.com/role/ConsolidatedStatementsOfShareholdersEquity" xlink:href="immy-20120630.xsd#ConsolidatedStatementsOfShareholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://imprimispharma.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows" xlink:href="immy-20120630.xsd#UnauditedCondensedConsolidatedStatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://imprimispharma.com/role/OverviewAndBasisOfPresentation" xlink:href="immy-20120630.xsd#OverviewAndBasisOfPresentation" xlink:type="simple" />
    <link:roleRef roleURI="http://imprimispharma.com/role/GoingConcern" xlink:href="immy-20120630.xsd#GoingConcern" xlink:type="simple" />
    <link:roleRef roleURI="http://imprimispharma.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="immy-20120630.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://imprimispharma.com/role/BankruptcyPetitionAndAssetPurchaseAgreement" xlink:href="immy-20120630.xsd#BankruptcyPetitionAndAssetPurchaseAgreement" xlink:type="simple" />
    <link:roleRef roleURI="http://imprimispharma.com/role/NotesPayable-RelatedParty" xlink:href="immy-20120630.xsd#NotesPayable-RelatedParty" xlink:type="simple" />
    <link:roleRef roleURI="http://imprimispharma.com/role/StockholdersEquity" xlink:href="immy-20120630.xsd#StockholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://imprimispharma.com/role/StockOptionPlan" xlink:href="immy-20120630.xsd#StockOptionPlan" xlink:type="simple" />
    <link:roleRef roleURI="http://imprimispharma.com/role/Warrants" xlink:href="immy-20120630.xsd#Warrants" xlink:type="simple" />
    <link:roleRef roleURI="http://imprimispharma.com/role/IncomeTaxes" xlink:href="immy-20120630.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://imprimispharma.com/role/CommitmentsAndContingencies" xlink:href="immy-20120630.xsd#CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://imprimispharma.com/role/OtherRelatedPartyTransactions" xlink:href="immy-20120630.xsd#OtherRelatedPartyTransactions" xlink:type="simple" />
    <link:roleRef roleURI="http://imprimispharma.com/role/ResearchAndDevelopmentCredit" xlink:href="immy-20120630.xsd#ResearchAndDevelopmentCredit" xlink:type="simple" />
    <link:roleRef roleURI="http://imprimispharma.com/role/GainOnForgivenessOfLiabilities" xlink:href="immy-20120630.xsd#GainOnForgivenessOfLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://imprimispharma.com/role/SubsequentEvents" xlink:href="immy-20120630.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://imprimispharma.com/role/BasisOfPresentationAndAccountingPoliciesPolicies" xlink:href="immy-20120630.xsd#BasisOfPresentationAndAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://imprimispharma.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:href="immy-20120630.xsd#SummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://imprimispharma.com/role/NotesPayable-RelatedPartyTables" xlink:href="immy-20120630.xsd#NotesPayable-RelatedPartyTables" xlink:type="simple" />
    <link:roleRef roleURI="http://imprimispharma.com/role/StockOptionPlanTables" xlink:href="immy-20120630.xsd#StockOptionPlanTables" xlink:type="simple" />
    <link:roleRef roleURI="http://imprimispharma.com/role/WarrantsTables" xlink:href="immy-20120630.xsd#WarrantsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://imprimispharma.com/role/IncomeTaxesTables" xlink:href="immy-20120630.xsd#IncomeTaxesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://imprimispharma.com/role/SummaryOfSignificantAccountingPoliciesDetails" xlink:href="immy-20120630.xsd#SummaryOfSignificantAccountingPoliciesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://imprimispharma.com/role/SummaryOfSignificantAccountingPoliciesDetails1" xlink:href="immy-20120630.xsd#SummaryOfSignificantAccountingPoliciesDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://imprimispharma.com/role/SummaryOfSignificantAccountingPoliciesdetails2" xlink:href="immy-20120630.xsd#SummaryOfSignificantAccountingPoliciesdetails2" xlink:type="simple" />
    <link:roleRef roleURI="http://imprimispharma.com/role/NotesPayable-RelatedPartyDetails" xlink:href="immy-20120630.xsd#NotesPayable-RelatedPartyDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://imprimispharma.com/role/StockOptionPlanDetails" xlink:href="immy-20120630.xsd#StockOptionPlanDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://imprimispharma.com/role/StockOptionPlanDetails1" xlink:href="immy-20120630.xsd#StockOptionPlanDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://imprimispharma.com/role/StockOptionPlanDetails2" xlink:href="immy-20120630.xsd#StockOptionPlanDetails2" xlink:type="simple" />
    <link:roleRef roleURI="http://imprimispharma.com/role/WarrantsDetails" xlink:href="immy-20120630.xsd#WarrantsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://imprimispharma.com/role/IncomeTaxesDetails" xlink:href="immy-20120630.xsd#IncomeTaxesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://imprimispharma.com/role/IncomeTaxesDetails1" xlink:href="immy-20120630.xsd#IncomeTaxesDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://imprimispharma.com/role/GoingConcernDetailsNarrative" xlink:href="immy-20120630.xsd#GoingConcernDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://imprimispharma.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="immy-20120630.xsd#SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://imprimispharma.com/role/NotesPayable-RelatedPartyDetailsNarrative" xlink:href="immy-20120630.xsd#NotesPayable-RelatedPartyDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://imprimispharma.com/role/StockOptionPlanDetailsNarrative" xlink:href="immy-20120630.xsd#StockOptionPlanDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://imprimispharma.com/role/StockholdersEquityDetailsNarrative" xlink:href="immy-20120630.xsd#StockholdersEquityDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://imprimispharma.com/role/StockholdersEquityDetailsNarrative1" xlink:href="immy-20120630.xsd#StockholdersEquityDetailsNarrative1" xlink:type="simple" />
    <link:roleRef roleURI="http://imprimispharma.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:href="immy-20120630.xsd#CommitmentsAndContingenciesDetailsNarrative" xlink:type="simple" />
    <link:calculationLink xlink:type="extended" xlink:role="http://imprimispharma.com/role/DocumentAndEntityInformation" xlink:title="0001 - Document - Document and Entity Information" />
    <link:calculationLink xlink:type="extended" xlink:role="http://imprimispharma.com/role/CondensedConsolidatedBalanceSheets" xlink:title="0002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_IMMYAssetsCurrent" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_IMMYCashAndCashEquivalentsAtCarryingValue" />
      <link:calculationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_IMMYAssetsCurrent" xlink:to="loc_IMMYCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_IMMYPrepaidExpenseAndOtherAssetsCurrent" />
      <link:calculationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_IMMYAssetsCurrent" xlink:to="loc_IMMYPrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DeferredOfferingCosts" xlink:label="loc_IMMYDeferredOfferingCosts" />
      <link:calculationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_IMMYAssetsCurrent" xlink:to="loc_IMMYDeferredOfferingCosts" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_Assets" xlink:label="loc_IMMYAssets" />
      <link:calculationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_IMMYAssets" xlink:to="loc_IMMYAssetsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_IMMYPropertyPlantAndEquipmentNet" />
      <link:calculationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_IMMYAssets" xlink:to="loc_IMMYPropertyPlantAndEquipmentNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_IMMYLiabilitiesCurrent" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilities" xlink:label="loc_IMMYAccountsPayableAndOtherAccruedLiabilities" />
      <link:calculationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_IMMYLiabilitiesCurrent" xlink:to="loc_IMMYAccountsPayableAndOtherAccruedLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="loc_IMMYEmployeeRelatedLiabilitiesCurrent" />
      <link:calculationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_IMMYLiabilitiesCurrent" xlink:to="loc_IMMYEmployeeRelatedLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DeferredRevenue" xlink:label="loc_IMMYDeferredRevenue" />
      <link:calculationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_IMMYLiabilitiesCurrent" xlink:to="loc_IMMYDeferredRevenue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ConvertibleNotesPayableCurrent" xlink:label="loc_IMMYConvertibleNotesPayableCurrent" />
      <link:calculationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_IMMYLiabilitiesCurrent" xlink:to="loc_IMMYConvertibleNotesPayableCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NotesPayableRelatedPartiesClassifiedCurrent" xlink:label="loc_IMMYNotesPayableRelatedPartiesClassifiedCurrent" />
      <link:calculationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_IMMYLiabilitiesCurrent" xlink:to="loc_IMMYNotesPayableRelatedPartiesClassifiedCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AccountsPayableRelatedPartiesCurrent" xlink:label="loc_IMMYAccountsPayableRelatedPartiesCurrent" />
      <link:calculationArc order="600" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_IMMYLiabilitiesCurrent" xlink:to="loc_IMMYAccountsPayableRelatedPartiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="loc_IMMYAccountsPayableAndAccruedLiabilitiesCurrent" />
      <link:calculationArc order="700" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_IMMYLiabilitiesCurrent" xlink:to="loc_IMMYAccountsPayableAndAccruedLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_IMMYLiabilities" />
      <link:calculationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_IMMYLiabilities" xlink:to="loc_IMMYLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ConvertibleNotesPayable" xlink:label="loc_IMMYConvertibleNotesPayable" />
      <link:calculationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_IMMYLiabilities" xlink:to="loc_IMMYConvertibleNotesPayable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_IMMYStockholdersEquity" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_IMMYPreferredStockValue" />
      <link:calculationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_IMMYStockholdersEquity" xlink:to="loc_IMMYPreferredStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_IMMYCommonStockValue" />
      <link:calculationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_IMMYStockholdersEquity" xlink:to="loc_IMMYCommonStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_IMMYAdditionalPaidInCapital" />
      <link:calculationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_IMMYStockholdersEquity" xlink:to="loc_IMMYAdditionalPaidInCapital" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage" xlink:label="loc_IMMYDevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage" />
      <link:calculationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_IMMYStockholdersEquity" xlink:to="loc_IMMYDevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_IMMYLiabilitiesAndStockholdersEquity" />
      <link:calculationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_IMMYLiabilitiesAndStockholdersEquity" xlink:to="loc_IMMYStockholdersEquity" xlink:type="arc" weight="1" />
      <link:calculationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_IMMYLiabilitiesAndStockholdersEquity" xlink:to="loc_IMMYLiabilities" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://imprimispharma.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:title="0003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://imprimispharma.com/role/UnauditedCondensedConsolidatedStatementsOfOperations" xlink:title="0004 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_IMMYOperatingIncomeLoss" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LicensesRevenue" xlink:label="loc_IMMYLicensesRevenue" />
      <link:calculationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_IMMYOperatingIncomeLoss" xlink:to="loc_IMMYLicensesRevenue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="loc_IMMYSellingGeneralAndAdministrativeExpense" />
      <link:calculationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_IMMYOperatingIncomeLoss" xlink:to="loc_IMMYSellingGeneralAndAdministrativeExpense" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_IMMYResearchAndDevelopmentExpense" />
      <link:calculationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_IMMYOperatingIncomeLoss" xlink:to="loc_IMMYResearchAndDevelopmentExpense" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_OtherNonoperatingExpense" xlink:label="loc_IMMYOtherNonoperatingExpense" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_InterestExpense" xlink:label="loc_IMMYInterestExpense" />
      <link:calculationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_IMMYOtherNonoperatingExpense" xlink:to="loc_IMMYInterestExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_InvestmentIncomeInterest" xlink:label="loc_IMMYInvestmentIncomeInterest" />
      <link:calculationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_IMMYOtherNonoperatingExpense" xlink:to="loc_IMMYInvestmentIncomeInterest" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_GainLossRelatedToLitigationSettlement" xlink:label="loc_IMMYGainLossRelatedToLitigationSettlement" />
      <link:calculationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_IMMYOtherNonoperatingExpense" xlink:to="loc_IMMYGainLossRelatedToLitigationSettlement" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_IMMYGainsLossesOnExtinguishmentOfDebt" />
      <link:calculationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_IMMYOtherNonoperatingExpense" xlink:to="loc_IMMYGainsLossesOnExtinguishmentOfDebt" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="immy-20120630.xsd#IMMY_GainOnForgivenessOfLiabilities" xlink:label="loc_IMMYGainOnForgivenessOfLiabilities" />
      <link:calculationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_IMMYOtherNonoperatingExpense" xlink:to="loc_IMMYGainOnForgivenessOfLiabilities" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_IMMYNetIncomeLoss" />
      <link:calculationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_IMMYNetIncomeLoss" xlink:to="loc_IMMYOperatingIncomeLoss" xlink:type="arc" weight="1" />
      <link:calculationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_IMMYNetIncomeLoss" xlink:to="loc_IMMYOtherNonoperatingExpense" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="loc_IMMYNetIncomeLossAvailableToCommonStockholdersBasic" />
      <link:calculationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_IMMYNetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="loc_IMMYNetIncomeLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PreferredStockDividendsAndOtherAdjustments" xlink:label="loc_IMMYPreferredStockDividendsAndOtherAdjustments" />
      <link:calculationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_IMMYNetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="loc_IMMYPreferredStockDividendsAndOtherAdjustments" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://imprimispharma.com/role/ConsolidatedStatementsOfShareholdersEquity" xlink:title="0005 - Statement - CONSOLIDATED STATEMENTS OF SHAREHOLDERS EQUITY (Unaudited)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://imprimispharma.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows" xlink:title="0006 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_IMMYNetCashProvidedByUsedInOperatingActivities" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_IMMYNetIncomeLoss" />
      <link:calculationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_IMMYNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_IMMYNetIncomeLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="immy-20120630.xsd#IMMY_EstimatedFairValueOfContributedServices" xlink:label="loc_IMMYEstimatedFairValueOfContributedServices" />
      <link:calculationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_IMMYNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_IMMYEstimatedFairValueOfContributedServices" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="immy-20120630.xsd#IMMY_GainOnForgivenessOfLiabilities" xlink:label="loc_IMMYGainOnForgivenessOfLiabilities" />
      <link:calculationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_IMMYNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_IMMYGainOnForgivenessOfLiabilities" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="immy-20120630.xsd#IMMY_AmortizationOfPrepaidConsultingFees" xlink:label="loc_IMMYAmortizationOfPrepaidConsultingFees" />
      <link:calculationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_IMMYNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_IMMYAmortizationOfPrepaidConsultingFees" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_Depreciation" xlink:label="loc_IMMYDepreciation" />
      <link:calculationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_IMMYNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_IMMYDepreciation" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_IMMYGainsLossesOnExtinguishmentOfDebt" />
      <link:calculationArc order="600" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_IMMYNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_IMMYGainsLossesOnExtinguishmentOfDebt" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DebtInstrumentIncreaseAccruedInterest" xlink:label="loc_IMMYDebtInstrumentIncreaseAccruedInterest" />
      <link:calculationArc order="700" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_IMMYNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_IMMYDebtInstrumentIncreaseAccruedInterest" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_IMMYShareBasedCompensation" />
      <link:calculationArc order="800" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_IMMYNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_IMMYShareBasedCompensation" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt" xlink:label="loc_IMMYProceedsFromRepaymentsOfRelatedPartyDebt" />
      <link:calculationArc order="900" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_IMMYNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_IMMYProceedsFromRepaymentsOfRelatedPartyDebt" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="immy-20120630.xsd#IMMY_PrepaidConsultingCosts" xlink:label="loc_IMMYPrepaidConsultingCosts" />
      <link:calculationArc order="1000" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_IMMYNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_IMMYPrepaidConsultingCosts" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="loc_IMMYIncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" />
      <link:calculationArc order="1100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_IMMYNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_IMMYIncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="loc_IMMYIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
      <link:calculationArc order="1200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_IMMYNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_IMMYIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" xlink:label="loc_IMMYIncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" />
      <link:calculationArc order="1300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_IMMYNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_IMMYIncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:label="loc_IMMYIncreaseDecreaseInEmployeeRelatedLiabilities" />
      <link:calculationArc order="1400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_IMMYNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_IMMYIncreaseDecreaseInEmployeeRelatedLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:label="loc_IMMYIncreaseDecreaseInDeferredRevenue" />
      <link:calculationArc order="1500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_IMMYNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_IMMYIncreaseDecreaseInDeferredRevenue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_IMMYNetCashProvidedByUsedInInvestingActivities" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_IMMYPaymentsToAcquirePropertyPlantAndEquipment" />
      <link:calculationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_IMMYNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_IMMYPaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_IMMYNetCashProvidedByUsedInFinancingActivities" />
      <link:loc xlink:type="locator" xlink:href="immy-20120630.xsd#IMMY_ProceedsFromIssuanceOfNotesPayableToStockholders" xlink:label="loc_IMMYProceedsFromIssuanceOfNotesPayableToStockholders" />
      <link:calculationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_IMMYNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_IMMYProceedsFromIssuanceOfNotesPayableToStockholders" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="immy-20120630.xsd#IMMY_ProceedsReceivedInConnectionWithDebtModification" xlink:label="loc_IMMYProceedsReceivedInConnectionWithDebtModification" />
      <link:calculationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_IMMYNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_IMMYProceedsReceivedInConnectionWithDebtModification" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:label="loc_IMMYProceedsFromIssuanceOfPreferredStockAndPreferenceStock" />
      <link:calculationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_IMMYNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_IMMYProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ProceedsFromNotesPayable" xlink:label="loc_IMMYProceedsFromNotesPayable" />
      <link:calculationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_IMMYNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_IMMYProceedsFromNotesPayable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="immy-20120630.xsd#IMMY_PreferredStockDeemedDividendPaidAtConversion" xlink:label="loc_IMMYPreferredStockDeemedDividendPaidAtConversion" />
      <link:calculationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_IMMYNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_IMMYPreferredStockDeemedDividendPaidAtConversion" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ProceedsFromRelatedPartyDebt" xlink:label="loc_IMMYProceedsFromRelatedPartyDebt" />
      <link:calculationArc order="600" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_IMMYNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_IMMYProceedsFromRelatedPartyDebt" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_RepaymentsOfRelatedPartyDebt" xlink:label="loc_IMMYRepaymentsOfRelatedPartyDebt" />
      <link:calculationArc order="700" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_IMMYNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_IMMYRepaymentsOfRelatedPartyDebt" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ProceedsFromContributedCapital" xlink:label="loc_IMMYProceedsFromContributedCapital" />
      <link:calculationArc order="800" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_IMMYNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_IMMYProceedsFromContributedCapital" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:label="loc_IMMYProceedsFromWarrantExercises" />
      <link:calculationArc order="900" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_IMMYNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_IMMYProceedsFromWarrantExercises" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_IMMYProceedsFromIssuanceOfCommonStock" />
      <link:calculationArc order="1000" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_IMMYNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_IMMYProceedsFromIssuanceOfCommonStock" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredCharges" xlink:label="loc_IMMYIncreaseDecreaseInDeferredCharges" />
      <link:calculationArc order="1100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_IMMYNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_IMMYIncreaseDecreaseInDeferredCharges" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="loc_IMMYCashAndCashEquivalentsPeriodIncreaseDecrease" />
      <link:calculationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_IMMYCashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="loc_IMMYNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_IMMYCashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="loc_IMMYNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_IMMYCashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="loc_IMMYNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://imprimispharma.com/role/OverviewAndBasisOfPresentation" xlink:title="0007 - Disclosure - 1. OVERVIEW AND BASIS OF PRESENTATION" />
    <link:calculationLink xlink:type="extended" xlink:role="http://imprimispharma.com/role/GoingConcern" xlink:title="0008 - Disclosure - 2. GOING CONCERN" />
    <link:calculationLink xlink:type="extended" xlink:role="http://imprimispharma.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="0009 - Disclosure - 3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://imprimispharma.com/role/BankruptcyPetitionAndAssetPurchaseAgreement" xlink:title="0010 - Disclosure - 4. BANKRUPTCY PETITION AND ASSET PURCHASE AGREEMENT" />
    <link:calculationLink xlink:type="extended" xlink:role="http://imprimispharma.com/role/NotesPayable-RelatedParty" xlink:title="0011 - Disclosure - 5. NOTES PAYABLE - RELATED PARTY" />
    <link:calculationLink xlink:type="extended" xlink:role="http://imprimispharma.com/role/StockholdersEquity" xlink:title="0012 - Disclosure - 6. STOCKHOLDERS EQUITY" />
    <link:calculationLink xlink:type="extended" xlink:role="http://imprimispharma.com/role/StockOptionPlan" xlink:title="0013 - Disclosure - 7. STOCK OPTION PLAN" />
    <link:calculationLink xlink:type="extended" xlink:role="http://imprimispharma.com/role/Warrants" xlink:title="0014 - Disclosure - 8. WARRANTS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://imprimispharma.com/role/IncomeTaxes" xlink:title="0015 - Disclosure - 9. INCOME TAXES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://imprimispharma.com/role/CommitmentsAndContingencies" xlink:title="0016 - Disclosure - 10. COMMITMENTS AND CONTINGENCIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://imprimispharma.com/role/OtherRelatedPartyTransactions" xlink:title="0017 - Disclosure - 11. OTHER RELATED PARTY TRANSACTIONS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://imprimispharma.com/role/ResearchAndDevelopmentCredit" xlink:title="0018 - Disclosure - 12. RESEARCH AND DEVELOPMENT CREDIT" />
    <link:calculationLink xlink:type="extended" xlink:role="http://imprimispharma.com/role/GainOnForgivenessOfLiabilities" xlink:title="0019 - Disclosure - 13. GAIN ON FORGIVENESS OF LIABILITIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://imprimispharma.com/role/SubsequentEvents" xlink:title="0020 - Disclosure - 14. SUBSEQUENT EVENTS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://imprimispharma.com/role/BasisOfPresentationAndAccountingPoliciesPolicies" xlink:title="0021 - Disclosure - 3. BASIS OF PRESENTATION AND ACCOUNTING POLICIES (Policies)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://imprimispharma.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:title="0022 - Disclosure - 3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://imprimispharma.com/role/NotesPayable-RelatedPartyTables" xlink:title="0023 - Disclosure - 5. NOTES PAYABLE - RELATED PARTY (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://imprimispharma.com/role/StockOptionPlanTables" xlink:title="0024 - Disclosure - 7. STOCK OPTION PLAN (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://imprimispharma.com/role/WarrantsTables" xlink:title="0025 - Disclosure - 8. WARRANTS (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://imprimispharma.com/role/IncomeTaxesTables" xlink:title="0026 - Disclosure - 9. INCOME TAXES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://imprimispharma.com/role/SummaryOfSignificantAccountingPoliciesDetails" xlink:title="0027 - Disclosure - 3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://imprimispharma.com/role/SummaryOfSignificantAccountingPoliciesDetails1" xlink:title="0028 - Disclosure - 3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 1)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://imprimispharma.com/role/SummaryOfSignificantAccountingPoliciesdetails2" xlink:title="0029 - Disclosure - 3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES(Details 2)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://imprimispharma.com/role/NotesPayable-RelatedPartyDetails" xlink:title="0030 - Disclosure - 5. NOTES PAYABLE - RELATED PARTY (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://imprimispharma.com/role/StockOptionPlanDetails" xlink:title="0031 - Disclosure - 7. STOCK OPTION PLAN (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://imprimispharma.com/role/StockOptionPlanDetails1" xlink:title="0032 - Disclosure - 7. STOCK OPTION PLAN (Details 1)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://imprimispharma.com/role/StockOptionPlanDetails2" xlink:title="0033 - Disclosure - 7. STOCK OPTION PLAN (Details 2)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://imprimispharma.com/role/WarrantsDetails" xlink:title="0034 - Disclosure - 8. WARRANTS (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://imprimispharma.com/role/IncomeTaxesDetails" xlink:title="0035 - Disclosure - 9. INCOME TAXES (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://imprimispharma.com/role/IncomeTaxesDetails1" xlink:title="0036 - Disclosure - 9. INCOME TAXES (Details 1)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://imprimispharma.com/role/GoingConcernDetailsNarrative" xlink:title="0037 - Disclosure - 2. GOING CONCERN (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://imprimispharma.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="0038 - Disclosure - 3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://imprimispharma.com/role/NotesPayable-RelatedPartyDetailsNarrative" xlink:title="0039 - Disclosure - 5. NOTES PAYABLE - RELATED PARTY (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://imprimispharma.com/role/StockOptionPlanDetailsNarrative" xlink:title="0040 - Disclosure - 7. STOCK OPTION PLAN (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://imprimispharma.com/role/StockholdersEquityDetailsNarrative" xlink:title="0041 - Disclosure - 6. STOCKHOLDERS EQUITY (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://imprimispharma.com/role/StockholdersEquityDetailsNarrative1" xlink:title="0042 - Disclosure - 6. STOCKHOLDERS EQUITY (Details Narrative 1)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://imprimispharma.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:title="0043 - Disclosure - 10. COMMITMENTS AND CONTINGENCIES (Details Narrative)" />
</link:linkbase>
</XBRL>
